0.2409USD-20.74%Mkt Cap: 793724 USDP/E: —Last update: 2026-05-22
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include ATX-04, a smal…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap793.72K USD
Enterprise Value-1.50M USD
Revenue (TTM)1.40M USD
Gross Profit1.40M USD
Net Income (TTM)-2.91M USD
Revenue/Share0.4370 USD
Last Price0.2409 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.09
PEG—
EV/EBITDA—
EV/Revenue-1.07
P/S0.65
P/B0.76
EPS (TTM)-0.52
EPS (Forward)-3.14
52W Range
0.150011% of range0.9699
52W High0.9699 USD
52W Low0.1500 USD
Profitability
Gross Margin100.00%
Oper. Margin-149.22%
EBITDA Margin0.00%
Profit Margin-207.19%
ROE-158.79%
ROA-99.25%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.83M USD
CapEx (TTM)—
FCF Margin-51.24%
FCF Yield-90.63%
Net Debt-2.42M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio1.94
Quick Ratio1.90
Book Value/Sh0.3640 USD
Cash/Share0.7340 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:75
Split DateApr 26, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.29M
Float2.85M
Insiders20.64%
Institutions7.02%
Short Interest
Short Ratio0.7d
Short % Float2.83%
Short % Out.2.83%
Shares Short59.70K
Short (prev mo.)154.91K
Technical
SMA 500.4076 (-40.9%)
SMA 2000.5529 (-56.4%)
Beta-0.08
S&P 52W Chg28.31%
Avg Vol (30d)4.10K
Avg Vol (10d)4.95K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—